Terms: = Breast cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Diagnosis
25 results:
1. Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
Kim H; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH
PLoS One; 2022; 17(3):e0265533. PubMed ID: 35294484
[TBL] [Abstract] [Full Text] [Related]
2. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract] [Full Text] [Related]
3. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for breast cancer Theranostics.
Li L; Fu J; Wang X; Chen Q; Zhang W; Cao Y; Ran H
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3605-3621. PubMed ID: 33449625
[TBL] [Abstract] [Full Text] [Related]
4. Iron(II) phthalocyanine Loaded and AS1411 Aptamer Targeting Nanoparticles: A Nanocomplex for Dual Modal Imaging and Photothermal Therapy of breast cancer.
He Y; Wang M; Fu M; Yuan X; Luo Y; Qiao B; Cao J; Wang Z; Hao L; Yuan G
Int J Nanomedicine; 2020; 15():5927-5949. PubMed ID: 32848397
[TBL] [Abstract] [Full Text] [Related]
5. Detection of Circulating Tumor Cells in breast cancer Patients by Nanopore Sensing with Aptamer-Mediated Amplification.
Li X; Zhang P; Dou L; Wang Y; Sun K; Zhang X; Song G; Zhao C; Li K; Bai Y; Zeng X; Zhou C; Ying B; Chen J; Geng J
ACS Sens; 2020 Aug; 5(8):2359-2366. PubMed ID: 32388982
[TBL] [Abstract] [Full Text] [Related]
6. A label-free pfp-based photoelectrochemical biosensor for highly sensitive detection of PARP-1 activity.
Wang C; Li Y; Xu E; Zhou Q; Chen J; Wei W; Liu Y; Liu S
Biosens Bioelectron; 2019 Aug; 138():111308. PubMed ID: 31103013
[TBL] [Abstract] [Full Text] [Related]
7. Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.
Lee SB; Ko SS; Park CH; Nam SJ; Choi JE; Jung YS; Park WC; Son BH
Breast Cancer Res Treat; 2018 Nov; 172(2):273-282. PubMed ID: 30088179
[TBL] [Abstract] [Full Text] [Related]
8. Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy.
Zhu L; Zhao H; Zhou Z; Xia Y; Wang Z; Ran H; Li P; Ren J
Nano Lett; 2018 Mar; 18(3):1831-1841. PubMed ID: 29419305
[TBL] [Abstract] [Full Text] [Related]
9. A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy.
Deng L; Cai X; Sheng D; Yang Y; Strohm EM; Wang Z; Ran H; Wang D; Zheng Y; Li P; Shang T; Ling Y; Wang F; Sun Y
Theranostics; 2017; 7(18):4410-4423. PubMed ID: 29158836
[TBL] [Abstract] [Full Text] [Related]
10. Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing breast cancer diagnosis and Gene Transfection.
Gao D; Gao J; Xu M; Cao Z; Zhou L; Li Y; Xie X; Jiang Q; Wang W; Liu J
Mol Pharm; 2017 Apr; 14(4):984-998. PubMed ID: 28282145
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
Fang C; Wei XM; Zeng XT; Wang FB; Weng H; Long X
BMC Cancer; 2015 Nov; 15():920. PubMed ID: 26585467
[TBL] [Abstract] [Full Text] [Related]
12. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract] [Full Text] [Related]
13. Glutathione S-transferase M1, T1, and P1 genotypes and breast cancer risk: a study in a Portuguese population.
Ramalhinho AC; Fonseca-Moutinho JA; Breitenfeld L
Mol Cell Biochem; 2011 Sep; 355(1-2):265-71. PubMed ID: 21559761
[TBL] [Abstract] [Full Text] [Related]
14. Independent association of lobular involution and mammographic breast density with breast cancer risk.
Ghosh K; Vachon CM; Pankratz VS; Vierkant RA; Anderson SS; Brandt KR; Visscher DW; Reynolds C; Frost MH; Hartmann LC
J Natl Cancer Inst; 2010 Nov; 102(22):1716-23. PubMed ID: 21037116
[TBL] [Abstract] [Full Text] [Related]
15. Glutathione s-transferase polymorphisms in breast cancers of Thai patients.
Pongtheerat T; Treetrisool M; Purisa W
Asian Pac J Cancer Prev; 2009; 10(1):127-32. PubMed ID: 19469640
[TBL] [Abstract] [Full Text] [Related]
16. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis.
Vogl FD; Taioli E; Maugard C; Zheng W; Pinto LF; Ambrosone C; Parl FF; Nedelcheva-Kristensen V; Rebbeck TR; Brennan P; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1473-9. PubMed ID: 15342448
[TBL] [Abstract] [Full Text] [Related]
17. Glutathione S-transferases M1, T1, and P1 and breast cancer.
Millikan R; Pittman G; Tse CK; Savitz DA; Newman B; Bell D
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):567-73. PubMed ID: 10868690
[TBL] [Abstract] [Full Text] [Related]
18. Risk of breast cancer and changes in mammographic parenchymal patterns over time.
Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
Acta Oncol; 1998; 37(6):547-51. PubMed ID: 9860312
[TBL] [Abstract] [Full Text] [Related]
19. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract] [Full Text] [Related]
20. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma.
Vikić-Topić S; Raisch KP; Kvols LK; Vuk-Pavlović S
J Clin Endocrinol Metab; 1995 Oct; 80(10):2974-9. PubMed ID: 7559883
[TBL] [Abstract] [Full Text] [Related]
[Next]
